Share on LinkedInShare on LinkedIn

ARTICLE · 06 JUNE 2025

Market Intelligence Thought Leadership Award Winner

Digging Deep To Avoid Scratching The Surface: The Quest For Non-Invasive Glucose Monitoring Solutions Continues

Marks & Clerk
Marks & Clerk
Contributor
Marks & Clerk

Marks & Clerk

Marks & Clerk LLP was founded in 1887 by George Croydon Marks, who was joined in partnership by...

View firm profile
Explore more from Marks & Clerk

26 May – 1 June 2025 was Type 2 Diabetes Prevention Week in the UK, a joint campaign run by NHS England and Diabetes UK to raise awareness of the risk of Type 2 Diabetes and how to avoid it.

United KingdomIntellectual Property

26 May – 1 June 2025 was Type 2 Diabetes Prevention Week in the UK, a joint campaign run by NHS England and Diabetes UK to raise awareness of the risk of Type 2 Diabetes and how to avoid it.

This campaign also serves to highlight the growing global prevalence of Type 2 diabetes and the growing global market for Continuous Glucose Monitoring (CGM) solutions - a market which the Med Tech industry is working hard to address. Existing CGM solutions that require piercing of the skin have been available on prescription in many countries around the world for several years. In March 2024, the U.S. Food and Drug Administration (FDA) also approved the first over-the-counter CGM solution for non-insulin users who are aged 18 or over. However, to date, none of the FDA-approved CGM solutions are truly non-invasive with the result that the long and well-documented quest for accurate and reliable truly non-invasive glucose monitoring (NIGM) solutions continues1.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from